Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
1997 1
1999 2
2000 5
2001 1
2002 2
2003 3
2004 6
2005 1
2006 9
2007 3
2008 5
2009 2
2010 4
2011 6
2012 2
2013 2
2014 3
2015 1
2016 1
2017 1
2018 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

56 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and safety of adalimumab in patients with ankylosing spondylitis: results of a multicenter, randomized, double-blind, placebo-controlled trial.
van der Heijde D, Kivitz A, Schiff MH, Sieper J, Dijkmans BA, Braun J, Dougados M, Reveille JD, Wong RL, Kupper H, Davis JC Jr; ATLAS Study Group. van der Heijde D, et al. Among authors: schiff mh. Arthritis Rheum. 2006 Jul;54(7):2136-46. doi: 10.1002/art.21913. Arthritis Rheum. 2006. PMID: 16802350 Free article. Clinical Trial.
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2009.
Furst DE, Keystone EC, Fleischmann R, Mease P, Breedveld FC, Smolen JS, Kalden JR, Braun J, Bresnihan B, Burmester GR, De Benedetti F, Dörner T, Emery P, Gibofsky A, Kavanaugh A, Kirkham B, Schiff MH, Sieper J, Singer N, Van Riel PL, Weinblatt ME, Weisman MH, Winthrop K. Furst DE, et al. Among authors: schiff mh. Ann Rheum Dis. 2010 Jan;69 Suppl 1:i2-29. doi: 10.1136/ard.2009.123885. Ann Rheum Dis. 2010. PMID: 19995740 No abstract available.
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2008.
Furst DE, Keystone EC, Kirkham B, Kavanaugh A, Fleischmann R, Mease P, Breedveld FC, Smolen JS, Kalden JR, Burmester GR, Braun J, Emery P, Winthrop K, Bresnihan B, De Benedetti F, Dörner T, Gibofsky A, Schiff MH, Sieper J, Singer N, Van Riel PL, Weinblatt ME, Weisman MH. Furst DE, et al. Among authors: schiff mh. Ann Rheum Dis. 2008 Dec;67 Suppl 3:iii2-25. doi: 10.1136/ard.2008.100834. Ann Rheum Dis. 2008. PMID: 19022808 No abstract available.
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2007.
Furst DE, Breedveld FC, Kalden JR, Smolen JS, Burmester GR, Sieper J, Emery P, Keystone EC, Schiff MH, Mease P, van Riel PL, Fleischmann R, Weisman MH, Weinblatt ME. Furst DE, et al. Among authors: schiff mh. Ann Rheum Dis. 2007 Nov;66 Suppl 3(Suppl 3):iii2-22. doi: 10.1136/ard.2007.081430. Ann Rheum Dis. 2007. PMID: 17934088 Free PMC article. Review. No abstract available.
Integrated safety in tocilizumab clinical trials.
Schiff MH, Kremer JM, Jahreis A, Vernon E, Isaacs JD, van Vollenhoven RF. Schiff MH, et al. Arthritis Res Ther. 2011;13(5):R141. doi: 10.1186/ar3455. Epub 2011 Sep 1. Arthritis Res Ther. 2011. PMID: 21884601 Free PMC article. Clinical Trial.
56 results